Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03892798 · ClinicalTrials.gov registry record
Database Of Clinical Data For Individuals With Variants In The IRF2BPL Gene
A clinical trial of Autism Spectrum Disorder and Seizures, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- 34
- Enrollment target
- 1
- Study location
NCT03892798 is a study of Autism Spectrum Disorder and Seizures that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 34 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03892798, a study of Autism Spectrum Disorder and Seizures, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
This protocol serves as a data collection tool for individuals with variants (missense, nonsense, frameshifts) in the IRF2BPL gene (MIM 611720), which causes Neurodevelopmental Regression, Seizures, Autism and Developmental Delay (NEDAMSS, MIM 618088) and may be involved in other neurodevelopmental presentations. This information will be analyzed to develop a better understanding of the findings and progression of symptoms in individuals with variants in the IRF2BPL gene.
Conditions Studied
Interventions
- OTHER No interventions are planned
Study Locations (1)
Ohio
- Cincinnati Children's - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2018-11-27 |
| Est. Completion | 2024-05-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03892798
The ClinicalTrials.gov registry entry for NCT03892798 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (75% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which No interventions are planned is the first listed.
NCT03892798 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03892798 about?
NCT03892798 is a clinical study titled "Database Of Clinical Data For Individuals With Variants In The IRF2BPL Gene". This protocol serves as a data collection tool for individuals with variants (missense, nonsense, frameshifts) in the IRF2BPL gene (MIM 611720), which causes Neurodevelopmental Regression, Seizures, Autism and Developmental Delay (NEDAMSS, MIM 618088) and may be involved in other neurodevelopmental ...
What is the current status of trial NCT03892798?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2018-11-27. Estimated completion is 2024-05-17.
What conditions does trial NCT03892798 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Seizures, Dystonia, Movement Disorders, NEDAMSS.
What interventions are being tested in trial NCT03892798?
The interventions under investigation include: No interventions are planned (OTHER).
Who is sponsoring clinical trial NCT03892798?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03892798 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design
RECRUITING · Early Phase 1
-
Cannabidiol (CBD) in Adults With ASD
RECRUITING · Phase 1
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
RECRUITING · Phase 2
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.